TARRYTOWN, N.Y., Oct. 6 /PRNewswire-FirstCall/ -- State, county and local government leaders today joined senior management from Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) and BioMed Realty Trust, Inc. (NYSE: BMR) to celebrate the completion of Regeneron's new 229,000 square foot corporate headquarters and research facility at BioMed's The Landmark at Eastview campus in Tarrytown, New York. Featured speakers at the ceremony were Leonard S. Schleifer, M.D., Ph.D., Founder, President and Chief Executive Officer of Regeneron; Kent Griffin, President and Chief Financial Officer of BioMed; Susan Tolchin, Deputy Westchester County Executive; New York State Senator Suzi Oppenheimer; Paul Feiner, Greenburgh Town Supervisor; and Dennis Mullen, Chairman and Chief Executive Officer Designate of the Empire State Development Corporation.
The $115 million investment in this state-of-the-art complex, one of the largest corporate facilities to be built in Westchester County in recent years, represents a major commitment to the county and state by Regeneron and BioMed and solidifies The Landmark at Eastview as the region's premier life science campus.
"Our new headquarters and research facility at Landmark provide the efficient and modern facilities we need for our operations," sai
|SOURCE BioMed Realty Trust, Inc.; Regeneron Pharmaceuticals, Inc.|
Copyright©2009 PR Newswire.
All rights reserved